Senior Advisor, Clinical Science
Eli Lilly and Company
Summary
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa is seeking a Senior Advisor, Clinical Science to provide scientific and clinical leadership for the design, execution, and interpretation of early-stage (Phase 1/2) clinical trials for Orexin-targeted programs in neurodegeneration and neuropsychiatric indications.
Job description
Responsibilities
- Serve as clinical scientist lead on one or more early-stage (Phase 1/2) clinical trials for Orexin-targeted programs in neurodegeneration and/or neuropsychiatric indications.
- Contribute to clinical development plan strategy, including study design, dose-escalation/titration strategy, and data interpretation.
- Lead the development, authorship, and review of key clinical and cross-functional documents, including protocols, amendments, investigator brochures, eCRFs, completion guidelines, SAP/TLF shells, and regulatory briefing materials.
- Serve as study medical/scientific lead from study start-up through clinical study report completion, including CRF design, enrollment monitoring, and patient profile review.
- Drive dose-escalation and study conduct discussions through real-time review and interpretation of emerging safety, PK/PD, and biomarker data.
- Provide scientific leadership and recommendations in data review meetings, safety review committees, governance forums, and cross-functional team discussions.
- Serve as a core scientific leader on cross-functional program/study teams, partnering closely with Clinical Operations, Translational Science, Regulatory Affairs, Biostatistics, and Safety/Pharmacovigilance.
- Drive alignment and execution across functions to support high-quality, timely study delivery.
- Collaborate with Translational and Preclinical teams to integrate biomarker and mechanistic hypotheses into clinical studies and broader development strategy.
- Proactively identify and address scientific, operational, and strategic risks and gaps.
- Lead ongoing review and interpretation of clinical data, including safety, efficacy, PK/PD, and exploratory biomarkers.
- Develop clear scientific insights and recommendations to inform clinical development strategy and decision-making.
- Contribute to regulatory submissions, health authority responses, internal governance materials, and external scientific communications.
- Support preparation of abstracts, posters, manuscripts, and presentations for scientific meetings and publications.
- Provide scientific leadership in interactions with investigators, CROs, vendors, and external experts to support high-quality trial execution.
- Lead or support investigator meetings and scientific training sessions.
- Represent clinical science in interactions with key opinion leaders and scientific advisory boards in neurodegeneration and neuropsychiatric disease areas.
- Ensure strong organization, follow-through, and proactive management of deliverables across assigned studies and workstreams.
- Mentor and support the development of junior clinical scientists (scope dependent on level).
Basic Qualifications
- Advanced scientific/clinical degree (PhD or PharmD strongly preferred)
- 8-10 years of experience in clinical research or clinical development within the biotechnology or pharmaceutical industry.
- Strong scientific foundation in neuroscience/neurology required; experience in neurodegeneration and/or neuropsychiatric indications strongly preferred.
- Familiarity with Orexin biology or related sleep/wake and neurocircuitry mechanisms a plus.
- Deep understanding of clinical trial design, clinical data analysis, and drug development principles, with direct experience leading or supporting early-phase (Phase 1/2) clinical trials.
- Demonstrated ability to independently lead complex scientific workstreams and influence cross-functional teams in a fast-paced biotech environment.
- Proven experience leading the development and authorship of clinical and regulatory documents (e.g., protocols, IBs, CSRs, briefing documents).
- Strong analytical and scientific interpretation skills, including the ability to synthesize emerging clinical, safety, and biomarker data into actionable insights.
- Excellent written and verbal communication skills, with the ability to clearly communicate complex scientific concepts to diverse audiences.
Work Location: The Senior Advisor, Clinical Science role is a remote role based in the US, with occasional travel.
Requirements
- Advanced scientific/clinical degree (PhD or PharmD strongly preferred)
- 8-10 years of experience in clinical research or clinical development within the biotechnology or pharmaceutical industry
- Strong scientific foundation in neuroscience/neurology required
- Experience in neurodegeneration and/or neuropsychiatric indications strongly preferred
- Familiarity with Orexin biology or related sleep/wake and neurocircuitry mechanisms a plus
- Deep understanding of clinical trial design, clinical data analysis, and drug development principles
- Direct experience leading or supporting early-phase (Phase 1/2) clinical trials
- Demonstrated ability to independently lead complex scientific workstreams and influence cross-functional teams
- Proven experience leading the development and authorship of clinical and regulatory documents (e.g., protocols, IBs, CSRs, briefing documents)
- Strong analytical and scientific interpretation skills
- Excellent written and verbal communication skills
Benefits
- 401(k) Matching
- Pension
- Vacation Benefits
- Medical, Dental & Vision
- Prescription Drug Benefits
- Flexible Spending Accounts
- Life Insurance
- Death Benefits
- Employee Assistance Program
- Fitness Benefits
- Employee Clubs & Activities
- Company Bonus
Company overview
Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical corporation headquartered in Indianapolis, Indiana. Founded in 1876 by Colonel Eli Lilly, the company has grown into one of the world's most valuable pharmaceutical enterprises, with operations in approximately 125 countries. Lilly specializes in developing and manufacturing innovative medicines across multiple therapeutic areas, including diabetes, oncology, neuroscience, immunology, and cardiometabolic diseases. The company is renowned for its groundbreaking work in insulin production, having been the first to mass-produce insulin and later developing the first commercially available insulin product in the U.S. Lilly's current portfolio includes blockbuster medications such as Mounjaro and Zepbound (tirzepatide) for diabetes and obesity, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for breast cancer, and Taltz (ixekizumab) for autoimmune conditions. With approximately 47,000 employees worldwide, Lilly maintains a strong commitment to research and development, investing heavily in scientific innovation to address some of the world's most significant health challenges. The company operates with a mission to make life better for people around the world through the discovery and delivery of innovative medicines.